In addition, although the endogenous RANKL levels of CRC cells were very low (Fig. S4a), perturbation of endogenous RANKL by denosumab significantly attenuated migration and invasion of SW480RK and Caco2RK cells (Fig. S4b, c). This evidence concerns the gene TNFSF11 and colorectal carcinoma.